Area of Research: DNA Repair and Analysis

2022 Grant Recipients

• Maria Victoria Botuyan, PhD, Mayo Clinic Rochester
  Liz Tilberis Early Career Award
  Probing How RAD18 and BARD1 Antagonize 53BP1 in HR DNA Repair

2021 Grant Recipients

• Bojana Stefanovska, PhD, University of Minnesota Twin Cities
  Ann and Sol Schreiber Mentored Investigator Award
  APOBEC3B and DNA Repair as Synthetic Lethal Combinations in CCOC
• Benoît Bragantini, PhD, Mayo Clinic
  Ann and Sol Schreiber Mentored Investigator Award
  Probing Homologous Recombination DNA Repair Factors in Chromatin by cryo-EM

2019 Grant Recipients

• John Krais, PhD, Fox Chase Cancer Center
  Ann and Sol Schreiber Mentored Investigator Award
  Examining the Role of RNF168 in BRCA1 Mutant Ovarian Cancer
• Marilyne Labrie, PhD, Oregon Health and Science University
  Ann and Sol Schreiber Mentored Investigator Award
  Synergistic Lethality of PARP and P13K Pathway Inhibitors in Ovarian Cancer
• Zihua Gong, MD, PhD, Cleveland Clinic
  Liz Tilberis Early Career Award
  DNA Repair Pathways as Targets for Therapy-Resistant Ovarian Cancer

2018 Grant Recipients

• Chin-Chi Chen, PhD, Johns Hopkins University
  Ann and Sol Schreiber Mentored Investigator Award
  Determining the Role of ARID1A in 53BP1-mediated DNA Damage Repair
• Maria Victoria Botuyan, PhD, Mayo Clinic
  Liz Tilberis Early Career Award
  Probing the Antagonistic Roles of 53BP1 and RAD18 in HR DNA Repair

2016 Grant Recipients

• Alberto Ciccia, PhD, Columbia University Medical Center
  Liz Tilberis Early Career Award
  Defining the Molecular Mechanisms of BRCA1-dependent Tumor Suppression
• Zihua Gong, MD, PhD, MD Anderson Cancer Center
  Liz Tilberis Early Career Award
  DNA Repair Pathways as Target for Therapy-Resistant Ovarian Cancer

2015 Grant Recipients

• Zeina Kais, PhD, Dana Farber Cancer Institute
  Ann and Sol Schreiber Mentored Investigator Award
  Synthetic Lethality Between CCNE1 Amplification and USP1 Inhibition
• Wei Wei, PhD, Massachusetts General Hospital
  Ann and Sol Schreiber Mentored Investigator Award
  Genomic Analysis to Predict Recurrence in Early Stage Ovarian Cancer
• Cesar Castro, MD, Massachusetts General Hospital
  Liz Tilberis Early Career Award
  Leveraging DNA-Barcoding for Integrated Profiling of Ovarian Cancer

2014 Grant Recipients

• Raphael Ceccaldi, PharmD, PhD, Dana Farber Cancer Institute
  Ann and Sol Schreiber Mentored Investigator Award
  A Bioinformatic Screen Identifies POLQ Overexpression in Ovarian Cancers

2009 Grant Recipients

• Kathryn Terry, ScD, Brigham and Women’s Hospital
  Liz Tilberis Early Career Award
  The Role of Genetics and Environment on Telomere Length in Ovarian Cancer

2006 Grant Recipients

• Kathryn Terry, ScD, Brigham and Women’s Hospital
  Liz Tilberis Early Career Award
  Telomeres and Telomerase in Relation to Ovarian Cancer Risk
• Peter Laird, PhD, University of Southern California/Keck Medical School
  Collaborative Research Development Grant
  Molecular Changes to DNA that Contribute to Ovarian Cancer

2005 Grant Recipients

• Ritu Salani, MD, Johns Hopkins University School of Medicine
  Ann and Sol Schreiber Mentored Investigator Award
  DNA Fragments Might be a Way to Screen for Ovarian Cancer

2003 Grant Recipients

• Susan K. Murphy, PhD, Duke University Medical Center
  Liz Tilberis Early Career Award
  How Chemical Alterations to the DNA-but not its Sequence-May Play a Role in Ovarian Cancer

2001 Grant Recipients

• Jingwei Yu, PhD, Eleanor Roosevelt Institute
  Individual Investigator Award
  Development of DNA Methylation Based Ovarian Cancer Specific Molecular Markers
• Paul Cairns, PhD, Fox Chase Cancer Center
  Individual Investigator Award
  Novel Approaches for Early Diagnosis of Ovarian Cancer